Latest filing published 22 Mar 2022 for Design Therapeutics, Inc., €9.5M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Stella Xu, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Design Therapeutics, Inc. and Tempest Therapeutics, Inc. Over a trading history stretching from 25 June 2021 to 18 March 2022, the count stands at 2 filings.
On the market, this insider has only sold: 1 sale, €9.5M in total. Other entries cover 1 share grant. Since January 2022: no purchases and 1 sale on the market.
Most recently, on 22 March 2022, the filings show an open-market sale worth €9.5M in Design Therapeutics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.